Sentence examples for may better respond from inspiring English sources

Third, studies included patients with ARF from various etiologies, some of which may better respond to NIV.

In an acute care setting, individual peer support programs may better respond to issues related to scheduling group meetings, while allowing for brief sessions and tailoring communication to address specific patient questions or concerns.

After informing the patient and his family of the final diagnosis and the possibility that diffuse large B cell lymphoma may better respond to chemotherapy, the patient visited the ER once again.

Based on these results, it may be hypothesized that the subset of tumors with high EGFR expression may better respond to lapatinib or dual HER blockade compared with trastuzumab alone.

As described above, our results revealed that the R genotype may better respond to chilling and freezing, with prior CA, through activating photosynthesis pathway related gene expression, in contrast to the S genotype.

The varied effects of vermicompost among different varieties of same genus indicate the role of genotype in specific response to any organic amendment (Zaller 2007; Lazcano et al. 2010) as some varieties may be more sensitive and better responding at specific dosage.

If this is the case, then perhaps the variation within "play actions" may better prepare an animal to respond adequately in future aggressive or sexual encounters.

Strategically located sub-regional care facilities could facilitate spatial access to services within a reasonable travel time, and may better positioned to assess and respond to the unique needs of local rural and remote areas than provincial or sub-provincial resource dissemination centres.

Moreover, patients may respond better to treatment and comply better with instructions when they are satisfied with their care and treatment setting, improving their health outcomes [ 19- 21].

Patients with pre-existing anti-Id T cells may respond better to vaccination as it may be easier to boost rather than induce de novo immunity against weak self-antigens.

CD27+ <26% at baseline may be a valuable threshold to distinguish TNFi nonresponders who may respond better to rituximab therapy.